Introduction ability of hematopoietic progenitor cells with retroviral Hematopoietic stem cells are desirable targets for gene vectors. therapy due to the ease with which they can be manipuAmphotropic or ecotropic retroviral envelope proteins lated ex vivo, their ability to self-renew, proliferate and can be substituted (pseudotyped) with envelope proteins differentiate into all lineages of the adult hematopoietic from other retroviruses, eg HIV 11 and gibbon ape leukesystem upon transplantation. 1 However, due to the rarity mia virus (GAL-V) 12 or other strains of viruses, eg rhaband quiescent nature of stem cells, 2-7 their genetic modidovirus vesicular stomatitis virus (VSV). [13] [14] [15] [16] Virus fication with amphotropic retroviral vectors has proven pseudotyping alters the range of cells susceptible to virus difficult.
. It is becoming increasingly apparent that the infection by conferring the receptor specificity of the amphotropic retroviral receptor RAM-1 is absent or envelope protein to the hybrid virus 17 and has been expressed at very low levels on murine and human stem applied to the formation of new generations of retroviral cells. [8] [9] [10] Cytokines have been shown to enhance amphovectors for stem cell transduction. Initial in vitro data on tropic binding to CD34 + cells, 9 but it has yet to be shown GAL-V pseudotyped retroviral vector infection of CD34 + whether this enhanced binding is due to increased levels cells have looked encouraging. 18 Like the amphotropic of receptor expression or enhanced binding affinity. Little receptor RAM-1, the GAL-V receptor (Galr-1) is a effect has been observed in the amphotropic retrovirus sodium-dependent phosphate transporter but is transduction efficiency when cytokines have been expressed at considerably higher levels in the bone marincluded in clinical transduction protocols, [5] [6] [7] suggesting row than RAM-1. 19 Although high levels of Galr-1 mRNA can be found in total bone marrow 19 this does not necessarily reflect the receptor expression pattern on bone marrow stem cells.
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pseudotyped retroviral vectors have a number of advantages over conventional amphotropic Moloney murine leukemia virus (MoMLV)-based retroviral vectors. The fact that the VSV-G gene is not derived from a retrovirus and has no homology with the retrovirus reduces the likelihood of recombination to produce replication-competent virus. In addition, VSV-G pseudotyped retroviral vectors can be concentrated 100-1000-fold by ultracentrifugation to achieve titers between 1 × 10 9 to 1 × 10 10 c.f.u./ml. 20, 21 This is in contrast to amphotropic or ecotropic viruses that are unstable when subjected to centrifugation. The VSV-G receptors appear to be ubiquitously present phospholipids, including PS, 22, 23 3 Therefore, to determine whether the enhanced binding of VSV-G pseudoAs the receptors for the VSV-G protein appear to be ubiquitously present phospholipids, including PS, 22, 23 we typed virus was due to putative enhancement of the VSV-G receptor or related to an increase in size and sursought to exclude the possibility that the phospholipid receptor for the VSV-G envelope was a potential limiting face area during cytokine-induced growth, cells with a similar forward (FSC) and side scatter (SSC) from cytofactor in the infection of CD34 + cells. Flow cytometry (FACS) with an anti-VSV-G monoclonal antibody 27 was kine-stimulated and unstimulated populations were compared for the level of virus binding at 37°C. Whilst used to quantify viral binding to CD34 + cells. First, a titration of viral binding was performed at 4°C (for bindenhanced viral binding to larger cells was observed in the cytokine-stimulated population (region R2 in Figure  ing alone) and at 37°C (for binding and fusion) on SCF and IL-3-stimulated CD34 + cells. At 4°C the fluorescence 3), cytokine-stimulated CD34 + cells with low FSC/SSC demonstrated enhanced VSV-G binding above that of the intensity did not increase above an MOI of 360, suggesting that the phospholipid receptors for VSV-G are at low unstimulated cells (region R1 in Figure 3 ). These data show that whilst there is a direct relationship between the levels on the surface of the cell (Figure 1) . However, at 37°C, which allows viral fusion to occur, no saturation size of a cell and the proportion of VSV-G pseudotyped retrovirus it binds, cytokines (IL-3 and SCF) can enhance was observed up to an MOI of 1080 ( Figure 1 ). These data demonstrate that cytokine-stimulated CD34
+ cells can binding of the retrovirus to its phospholipid receptor on small CD34 + cells. This suggests that cytokines can upregbind limited quantities of VSV-G pseudotyped retrovirus at 4°C but that binding with fusion is strongly enhanced ulate the levels of surface receptor and/or binding affinity to the receptor. at 37°C. Cytokines do not enhance levels of surface PS receptor VSV-G retrovirus binds and fuses to cytokine-stimulated CD34 + CD38 − cells on CD34 + cells On the basis of binding studies, PS is a strong candidate Our previous studies using VSV-G pseudotyped retrovirus to infect human hematopoietic stem cells found that for a major VSV-G receptor. 22, 23 Recently, annexin V, an anti-coagulation molecule, has been found to bind to sura block occurs in the infection processes before the completion of retroviral reverse transcription in cytokineface PS, and has been used as an early marker of apoptosis in some cells. 28 ,89 Therefore, we used FITC-labstimulated CD34 + CD38 − cells. 3 Therefore, we sought to determine whether the block to productive infection was eled annexin V binding to quantify the levels of surface PS on stimulated and nonstimulated CD34
+ cells, with due to the absence of binding and/or fusion of the VSV-G pseudotyped retrovirus to the CD34 + CD38 − population analysis restricted to cells with a small FSC and SSC. These cells were live, nonapoptotic cells, as shown by after cytokine stimulation. To determine whether this stem cell-containing population was binding virus, we negative PI staining (data not shown) and absence of the large increase in binding of annexin V associated with stained infected cytokine-stimulated CD34 + cells with an anti-CD38 antibody in addition to antibodies to CD34 apoptosis (Figure 4e) . 28 + cells may be due to an viral binding is present on the surface of cytokine-stimulated CD34 + CD38 − hematopoietic stem cells. increase in surface levels and/or binding affinity to other surface VSV-G receptors.
The detection of surface VSV-G by FACS analysis does − population for R18 staining determined that these cells increased in R18 fluorescence which is indicaulation was analyzed, no reverse-transcribed DNA product was detected. 
(a) Dot plot shows FSC and SSC of noncytokine-stimulated and (b) cytokine-stimulated CD34 + cells with region R1, to gate small live cells. Histograms show levels of annexin V binding to (c) noncytokine-stimulated and (d) cytokine-stimulated cells in corresponding R1 regions. No-stain controls are shown at the left hand side of the plots. (e) Positive control for annexin V and PI staining of ungated, cytokine stimulated CD34 + cells. Apoptotic cells (7% annexin V positive, PI negative/low) shown in the lower right quadrant and dead cells (13% annexin V positive, PI low/high) shown in the upper right quadrant. Live cells (80% annexin V negative, PI negative) are shown in the lower left quadrant.

Figure 5 FACS analysis of VSV-G pseudotyped retrovirus binding to CD34
+
CD38
− peripheral blood stem cells was performed after CD34 + cells were cultured for 48 h with cytokines. (a) Dot plot showing live cells gated in region R1 for virus binding analysis and phenotyping. (b) Cells were stained with an anti-CD34 antibody conjugated with Cy5-PE and an anti-CD38 antibody conjugated to PE with CD34
+
CD38
− cells gated in region R2. (c) Total CD34 + cells in region R1 were quantified for virus binding with anti-VSV-G mouse monoclonal I1 and a secondary FITC labeled anti-mouse IgG/M antibody, with nonvirus stain control shown in black. (d) CD34
+
CD38
− cells in region R2 were analyzed and show that VSV-G pseudotyped retrovirus can bind to this population.
binding was nonsaturable at 37°C up to an MOI of 1080.
demonstrated that retroviral infection of CD34 + cells was greatly stimulated by the addition of cytokines.
3 The This increase in viral binding may represent additional processing and surface presentation of receptor phosphoenhanced binding of retrovirus pseudotyped with VSV-G to cytokine-stimulated CD34 + cells is consistent with, lipid upon engagement with VSV-G during the infection period at 37°C. A temperature induced increase in bindand provides a possible mechanism for this enhanced transduction. 3 Cytokine stimulation does not however ing at 37°C has also been noted with the binding of ecotropic retrovirus to NIH 3T3 cells. 36 However, the virus appear to enhance the levels of surface PS on CD34 + cells, a strong receptor candidate for VSV-G. 22, 23 In some cell binding titration at 4°C is representative of the quantity of steady state receptor on the surface at that time and types, PS has been found to be confined to the inner leaflet of the membrane bilayer by an ATP-dependent indicates that whilst VSV-G pseudotyped retroviral binding occurs there are limited levels of receptor phosphoaminophospholipid translocase, 37-40 the down-regulation of which is associated with PS translocation to the outer lipid on cytokine stimulated CD34 + cells. We have also shown that in the absence of cytokines, surface upon apoptosis. 41 Although PS has been found to bind to VSV-G, 22, 23 this phospholipid may not be acting little binding of VSV-G occurs to CD34 + cells. However, by culturing CD34 + cells with SCF and IL-3, the levels of as the physiological receptor for productive VSV-Gmediated virus infections. Our data suggest that on VSV-G pseudotyped retrovirus binding can be enhanced on small primitive cells. This suggests that SCF and IL-3 CD34 + cells, cytokines IL-3 and SCF may enhance the surface levels/binding affinity to the other phospholipids can up-regulate the level of VSV-G receptor phospholipids or the affinity of viral binding to the receptor on associated with VSV-G binding, ie phosphatidylinositol, GM3 ganglioside, sphingomyelin and cholesterol. 22, 23 CD34 + cells to facilitate transduction. Our previous data Enhancement of phospholipid (phosphatidylcholine) Interestingly, the receptor induction occurs independently of the effects of cytokines on mitotic activity, 3 permetabolism has been observed upon cytokine (SCF and GM-CSF) induction in a factor-dependent hematopoietic haps making it possible to find culture conditions that induce the receptor without causing differentiation and cell line. 42 Therefore, it is conceivable that IL-3 and/or SCF are inducing surface levels of the phospholipid loss of long-term repopulating cells. 43 The recent development of HIV-based vectors [44] [45] [46] which can infect receptor(s) to enhance VSV-G pseudotyped retroviral binding. We are presently analyzing in more detail the mitotically inactive cells, 44,47 may eliminate the need to induce mitotic activity of hematopoietic progenitor and growth factor requirements for induction of VSV-G pseudotyped retroviral binding to CD34 + cells. stem cells for infection. Of note is the fact that the HIV vectors that have been developed use VSV-G as the The cytokine-induced increase in binding of VSV-G pseudotyped retrovirus is important because some clinienvelope protein. Thus, the studies described here are also relevant to the use of HIV-based vectors. cal gene therapy protocols have used hematopoietic cells that have not been exposed to cytokines. 6 The binding We have previously shown that CD34 + CD38 − cells do not support retroviral transcription of MoMLV-based data reported here together with our previous transduction study, 3 demonstrates that induction of the VSV-G retroviral vectors. 3 As we have demonstrated that CD34 + CD38 − cells can both bind and fuse VSV-G pseudoreceptor with cytokines is likely to be required for productive infection of hematopoietic progenitor cells.
typed retrovirus, we therefore propose that the intra-925 cellular environment within these early, quiescent pro-USA) for 15, 20 and 25 min, respectively, at 4°C in the dark. CD34 + cells (cultured as described above) were genitors must be nonpermissive for complete reverse transcription of retroviral vectors. In HIV infection of washed in PBS, 4 g/ml protamine sulfate added and infected with labeled virus at an MOI of 100 for 1 h in quiescent lymphocytes, reverse transcription is arrested at the stage of minus strand synthesis, 48 perhaps due to the dark at 37°C to measure virus fusion by dequenching of R18 fluorescence, and at 4°C to determine background low concentrations of cytoplasmic dNTPs. 49, 50 Experiments are in progress to determine which stage of reverse fluorescence associated with bound labeled virus (quenched) and contaminating R18 in the virus preptranscription is blocked in CD34 + CD38 − cells and the conditions necessary to permit the stable transduction of aration. It was confirmed that the increase in observed fluorescence at 37°C was due to dequenching of the R18 early hematopoietic progenitors.
labeled to the virus and not due to free R18 in the virus preparation by incubating an aliquot of R18 labeled virus
Materials and methods
with 20 l of 20 mg/ml proteinase K for 10 min at 37°C in the dark to remove the VSV-G protein. Cells were FACS analysis of VSV-G pseudotyped retroviral binding washed, immunophenotyped with anti-CD38 FITC-labPeripheral blood CD34
+ cells were isolated and cultured eled antibody, and R18 fluorescence was analyzed at 488 as previously described, and were between 85-95% nm excitation and Ͼ650 nm emission on a FACSStar pure.
3,51
Infections were performed as previously machine (Becton Dickinson, San José , CA). As R18 has a described, 3 0.5-3 ml capacity Slide-a-lyzer (Pierce, Rockford, IL,
